Includes a series of investments to acquire new equipment and adapt the present ROVI drug product fill-finish facilities and production lines in Spain.
£55 million investment includes a multipurpose ADC manufacturing and aseptic fill/finish facility in Grangemouth and enhanced API manufacturing in Morpeth.